According to Theravance Biopharma 's latest financial reports the company's current earnings are A$62.01 Million. In 2023 the company made an earning of -A$74.82 Million, an increase over its 2022 earnings that were of -A$0.15 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.